Astrup, et al.66, utilizaron la liraglutida para el tratamiento de la obesidad en 564 sujetos con ndice de masa corporal entre 30 y 40kg/m2, los cuales fueron asignados al azar a tres brazos: la liraglutida (cuatro dosis 1,2, 1,8, 2,8, 3mg), el orlistat o el placebo y los tres grupos recibieron una dieta con moderada restriccin calrica
Your data will be completely skewed, your conclusions will be incorrect, and you'll be left wondering why your results aren't reproducible
they think it has to be boring
39 Therapy with semaglutide resulted in significant weight loss, an increase in 6MWT distance, improvement in quality of life (KCCQ-CSS), and a significant reduction in CRP
The evaluation process has several steps
doi: 10.1007/s10753-020-01233-w 168 LinC.-Y.YaoC.-A